美东时间2020年5月20日,ZNTL股价今开45.2600美元,盘中最高48.6099美元,盘中最低37.5400美元,股价收跌8.04%,跌3.5900点,报41.0700美元

ZNTL简介

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.